Prospective Cohort Study to investigate factors affecting Health Related Quality of Life and the Effectiveness of Symptoms Monitoring via Computer-based Health Evaluation System (CHES) in Patients with Metastatic solid cancers during chemotherapy
Not Applicable
- Conditions
- Patients with metastatic solid cancer (gastric cancer, colorectal cancer and breast cancer) scheduled for first line chemotherapy (including molecular targeted drug and immune checkpoint inhibitor)
- Registration Number
- JPRN-UMIN000029663
- Lead Sponsor
- Kobe City Medical Center General Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 115
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with serious complications 2)Patients who have clinically problematic mental illness 3)Patients judged inappropriate for enrolment by physician
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method EQ-5D-5
- Secondary Outcome Measures
Name Time Method Global Health Status scale in EORTC QLQ-C30 EORTC QLQ-C30(five functional scales and three multi-item symptom scales) EORTC QLQ-CIPN20 Overall survival from the registration date Association between clinicopatholigical factors and HRQOL Association between sociodemographic factors and HRQOL Association between visiting emergency room and HRQOL Association between visiting palliative care unit and HRQOL Association between symptom monitoring via Patient Portal Site and HRQO